PIK3CA and acute myeloid leukemia: Two networks were constructed based on the edge enrichment of kinase-kinase relationships (see Network construction), measured as z-scores, of AML cells treated separately with the kinase inhibitors GDC0941 (a PIK3CA/PI3K inhibitor) and AZD5363 (AKT inhibitor).